Determining optimal prostate-specific antigen thresholds to identify an increased 4-year risk of prostate cancer development: an analysis within the Veterans Affairs Health Care System
Crossref DOI link: https://doi.org/10.1007/s00345-015-1754-6
Published Online: 2016-01-11
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sutton, S. Scott
Crawford, E. David
Moul, Judd W.
Hardin, James W.
Kruep, Eric
Funding for this research was provided by:
10380 (Glaxo Smith Kline)
Text and Data Mining valid from 2016-01-11